Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia (2025)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; PARISE FILHO, ROBERTO - FCF ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; GARNIQUE, ANALÍ DEL MILAGRO BERNABÉ - ICB ; CARLOS, JORGE ANTONIO ELIAS GODOY - ICB ; PARDUCCI, NATÁLIA SUDAN - ICB ; TAVARES, MAURICIO TEMOTHEO - FCF ; WAITMAN, KAROLINE DE BARROS - FCF ; LIMA, KELI CRISTINA DE - FM
- Unidades: ICB; FCF; FM
- DOI: 10.1016/j.htct.2025.103757
- Subjects: FARMACOLOGIA; NEOPLASIAS POR TIPO HISTOLÓGICO; LINFÓCITOS B; CÉLULAS CULTIVADAS DE TUMOR; ANTINEOPLÁSICOS; LEUCEMIA MIELOIDE AGUDA; CROMATINA; INIBIDORES DE ENZIMAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: São José do Rio Preto
- Date published: 2025
- Source:
- Título: Hematology, Transfusion and Cell Therapy
- ISSN: 2531-1387
- Volume/Número/Paginação/Ano: v. 47, n. 2, art. 103757, 5 p., 2025
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
GARNIQUE, Anali Del Milagro Bernabe et al. Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2025.103757. Acesso em: 04 ago. 2025. , 2025 -
APA
Garnique, A. D. M. B., Carlos, J. A. E. G., Parducci, N. S., Tavares, M. T., Waitaman, K. de B., Lima, K., et al. (2025). Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.htct.2025.103757 -
NLM
Garnique ADMB, Carlos JAEG, Parducci NS, Tavares MT, Waitaman K de B, Lima K, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2025 ; 47( 2): 5 .[citado 2025 ago. 04 ] Available from: https://doi.org/10.1016/j.htct.2025.103757 -
Vancouver
Garnique ADMB, Carlos JAEG, Parducci NS, Tavares MT, Waitaman K de B, Lima K, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2025 ; 47( 2): 5 .[citado 2025 ago. 04 ] Available from: https://doi.org/10.1016/j.htct.2025.103757 - Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia
- Enhancing venetoclax efficacy in leukemia through association with HDAC inhibitors
- Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models
- Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models
- miRNAs as prognostic predictors in acute myeloid leukemia [Editorial]
- The survivin/XIAP suppressant YM155 impairs clonal growth and induces apoptosis in JAK2V617F cells
- Exploring the dual role of SIVA1 in cancer biology
- Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment
- A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells
- Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs
Informações sobre o DOI: 10.1016/j.htct.2025.103757 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
